vc
A16z's $15bn mega-raise: 5 key takeaways
Insight Partners sued for gender discrimination - all the details here
IPOs are back, but VC returns are not
Biotech is back as Sofinnova and Medicxi close major VC funds
Lexington leads Lakestar's debut VC continuation vehicle